Trials / Completed
CompletedNCT01436578
Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)
Post Marketing Surveillance for General Drug Use to Assess the Safety and Efficacy Profile of NOXAFIL Oral Suspension in Usual Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 273 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will examine the safety and efficacy of posaconazole in general use in Korea. Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Posaconazole oral suspension 40 mg/mL | Posaconazole oral suspension prescribed according to the current local label |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2011-09-19
- Last updated
- 2015-07-07
Source: ClinicalTrials.gov record NCT01436578. Inclusion in this directory is not an endorsement.